Stichting Gezondheidscentra Eindhoven (SGE) Smoking Cessation Innovation.

Stichting Gezondheidscentra Eindhoven (SGE) Smoking Cessation Innovation. - COVACO

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON36281

Enrollment

272

Registered

2009-11-24

Start date

2011-09-20

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Smoking tobacco use

Interventions

The design of this study will be a randomized, parallel group, open label trial, comparing two intervention groups: the combination treatment of varenicline and individual counselling (group "VC") a

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: daily smoker 18 years of age or older

Exclusion criteria

Exclusion criteria: Contra-indications for the use of varenicline

Design outcomes

Primary

Measure	Time frame
Prolonged absinence from smoking from week 9 through week 26. Exhaled carbon monoxide (CO) will be measured, CO-levels of	—

Secondary

Measure	Time frame
Intervention costs per quitter Cost-effectiveness ratio Compliance with the use of varenicline	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)